跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Febuliv 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Febuliv 40
Approved
STANDARD
Febuliv 40
RV Lifesciences Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e19db79cb89670ef
Company
RV Lifesciences Limited
Type
Standard
Approval Details
Approval Id
e19db79cb89670ef
Drug Approval Philippines Name
Febuliv 40
Product Name
Febuliv 40
Registration Number
DRP-13982
Brand Name
Febuliv 40
Generic Name
Febuxostat
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
RV Lifesciences Limited
Importer
RV Group Phil. Branch
Distributor
RV Group Phil. Branch
Issuance Date
27 May 2024
Expiry Date
31 May 2028
Pharmacologic Category
Anti-gout (Preparation Inhibiting Uric Acid Production)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e19db79cb89670ef
Type
Standard
Back to Philippines FDA Approvals